BridgeBio Pharma’s License Agreement with Bristol Myers Squibb

Martina Bellini
Tagged:

Goodwin Procter advised BridgeBio Pharma, Inc. on the deal.BridgeBio Pharma, Inc. (Nasdaq: BBIO) announced its exclusive license agreement wit Bristol Myers Squibb to develop and commercialize…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Martina Bellini

Author: Martina Bellini

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here